Search for dissertations about: "Per Andrén"
Showing result 1 - 5 of 19 swedish dissertations containing the words Per Andrén.
-
1. Improved Neuropeptide Identification : Bioinformatics and Mass Spectrometry
Abstract : Bioinformatic methods were developed for improved identification of endogenous peptides using mass spectrometry. As a framework for these methods, a database for endogenous peptides, SwePep, was created. It was designed for storing information about endogenous peptides including tandem mass spectra. READ MORE
-
2. Development and Application of Software Tools for Mass Spectrometry Imaging
Abstract : Mass spectrometry imaging (MSI) has been extensively used to produce qualitative maps of distributions of proteins, peptides, lipids, neurotransmitters, small molecule pharmaceuticals and their metabolites directly in biological tissue sections. Moreover, during the last 10 years, there has been growing demand to quantify target compounds in tissue sections of various organs. READ MORE
-
3. Neuropeptidomics – Methods and Applications
Abstract : The sequencing of genomes has caused a growing demand for functional analysis of gene products. This research field named proteomics is derived from the term proteome, which by analogy to genome is defined as all proteins expressed by a cell or a tissue. READ MORE
-
4. Neuropeptidomics – Expanding Proteomics Downwards
Abstract : Biological function is mainly carried out by a dynamic population of proteins which may be used as markers for disease diagnosis, prognosis, and as a guide for effective treatment. In analogy to genomics, the study of proteins is called proteomics and it is generally performed by two-dimensional gel electrophoresis and mass spectrometric methods. READ MORE
-
5. Improving access to behaviour therapy for young people with Tourette syndrome
Abstract : Tourette syndrome (TS) and Chronic Tic Disorder (CTD) are childhood-onset neurodevelopmental disorders characterised by motor and vocal tics. Treatment guidelines recommend behaviour therapy (BT) as the first-line treatment for TS/CTD, but availability is generally low. READ MORE